swelling and proliferation of endothelial cells. No signs of TMA were observed. Immunofluorescence microscopy was strongly positive for complement C3 in a starry sky distribution, without concomitant immunoglobulin depositions. Electron microscopy showed electron dense deposits along the endothelial side of the glomerular basement membrane.
Our patient presented with an acute nephritic syndrome with renal failure after anti-VEGF therapy for a metastasized renal cell carcinoma. The kidney biopsy showed an acute exudative immune-complex glomerulonephritis as can be seen after infections, during cryoglobulinaemia or in early MPGN.
Toxicity of the newer anti-VEGF drug sunitinib seems the most likely explanation as no other cause could be identified. Another possibility would be a renal tumourrelated glomerulonephropathy, a rare entity associated with a variety of unrelated histopathological diagnosis [3] . Formally, we cannot exclude this possibility but the acute onset of glomerulonephritis and time relationship with sunitinib treatment argue against such a diagnosis. With the growing use of anti-VEGF therapeutics, unexpected renal side effects, specifically TMA [4, 5] , become apparent.
Our findings describe a histopathological picture that has not been reported before with the use of anti-VEGF blockers, specifically with the newest agent sunitinib. It adds on the recent findings of Bollee et al. [2] and Winn et al. [1] who reported cases of TMA and acute interstitial nephritis, respectively. Based on the information available now, different histopathological patterns can be elicited by sunitinib. Therefore, it seems advisable that during anti-VEGF therapy, kidney function and the urine sediment are monitored carefully and a kidney biopsy is taken when proteinuria or renal insufficiency develops. Unexpectedly high incidence of brucellosis in one university dialysis unit of North East Greece
Sir, We enjoyed reading the paper by Tuba Turunç et al. [1] in which they reported a series of seven dialysis patients with brucellosis, and stated that brucellosis may be overlooked in patients with end-stage renal disease (ESRD) who undergo dialysis. Comprehensive relative reports are lacking from the literature. We report here our experience with an unexpectedly high incidence of brucellosis infection in our Dialysis Unit, in patients receiving renal replacement therapies.
Eight of 124 dialysis patients developed brucellosis during the 1-year period, while according to our records, there were no other episodes among the 284 dialysed patients during the previous 5 years. During that 5-year period, diagnosis of brucellosis was reported in 21 hospitalized patients in our hospital (mean annual incidence 5.2/100000 population), and in a total of 1246 cases from the entire Greek regions according to the records of the Ministry of Health (mean annual incidence 2.3/100000 population). All the patients were fed unpasteurized milk and cheese. Common clinical manifestations were mild fever (100%), malaise (100%), lost of appetite (87.5%) and fatigue (100%). Diagnosis was established by PCR. The patients were treated with oral doxycycline and oral rifampicin for at least 6 weeks (for two of the patients, the treatment lasted for 8 weeks). The patients were followed up for 1 year. There were no relapses, and PCR were negative in all the patients.
Brucellosis is endemic in Greece, and it constitutes a serious public health and economic problem in some rural areas. Though the data from the Hellenic Center for Infections Diseases Control (H.C.I.D.C.) indicate a gradually declining annual incidence, this might not represent the definite situation due to imprecise recording of new Brucella cases [2] . [3] . However, exacerbations in annual incidence of brucellosis (17.3-1110 per 100000 population) were observed in certain rural areas of Greece, despite the widespread vaccine programmes [4] . This may be due to incomplete epidemiological surveillance or uncontrolled animal movements across borders and transportation of dairy products [5, 3] .
Brucellosis is an infectious disease that can affect anyone, especially those who are more susceptible to infections, such as dialysis patients, particularly when they are living in agricultural and veterinary areas, so it should be considered as a possible cause of infection in cases of unexplained, long-duration fever, who live in agricultural areas (even in European Union). Reply Sir, Afsar, Yilmaz and Eyileten, with reference to our paper [1] , put forward the hypothesis that insulin resistance may be one of the mechanisms responsible for altered blood pressure profile in patients with uric acid kidney stone. In our
